Nationwide Rheumatoid Arthritis Studies

Patients needed to participate in clinical research study.

Scientists are now seeking patients to participate in three clinical research studies. Each study will evaluate the safety and effectiveness of an investigational drug, rituximab, in combination with methotrexate, as compared to using methotrexate alone.

The goal of current RA therapys is to maintain normal joint function by alleviating pain, preventing joint damage, and reducing joint swelling and stiffness. During the last decade, many new therapies have entered clinical practice for RA, however, a number of patients still do not respond adequately to the available therapys. There remains a significant unmet need for new, effective therapies for patients with this chronic condition.

To be eligible to participate in the studies, you must meet specific criteria including, but not limited to: have active RA, and be between the ages of 18 and 80. To learn more about the studies, call toll-free.

1-888-82-STUDY (78839) or visit www.StudyRA.com.



Posted by: Mark    Source